Flagship Pioneering Inc. Foghorn Therapeutics Inc. Transaction History
Flagship Pioneering Inc.
- $589 Million
- Q3 2024
A detailed history of Flagship Pioneering Inc. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Flagship Pioneering Inc. holds 12,674,120 shares of FHTX stock, worth $62.5 Million. This represents 20.03% of its overall portfolio holdings.
Number of Shares
12,674,120
Previous 12,674,120
-0.0%
Holding current value
$62.5 Million
Previous $72.9 Million
61.91%
% of portfolio
20.03%
Previous 8.71%
Shares
1 transactions
Others Institutions Holding FHTX
# of Institutions
80Shares Held
33.3MCall Options Held
8.7KPut Options Held
2.4K-
Bvf Inc San Francisco, CA5.3MShares$26.1 Million1.57% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.03MShares$14.9 Million0.52% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$11.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.73MShares$8.54 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY1.57MShares$7.76 Million1.62% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $205M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...